Updated:
Pitango HealthTech
Pitango HealthTech was formed in 2019 as a specialized spin-out from Pitango, one of Israel's largest venture capital firms, which has over $2.5B under...
Pitango HealthTech
Pitango HealthTech was formed in 2019 as a specialized spin-out from Pitango, one of Israel's largest venture capital firms, which has over $2.5B under management across multiple funds. The dedicated healthtech unit was led by Itai Green, formerly a partner at Pitango, and Shai Levy, previously a managing director at Pitango. The firm operates independently with its own investment mandate focused exclusively on digital health. The firm invests predominantly in Seed and Series A rounds, targeting companies that use software, AI, and data to transform healthcare delivery. Its portfolio includes Cynerio, a medical-device cybersecurity company; Eleos Health, an AI platform for behavioral health; and Ibex Medical Analytics, an AI-powered pathology platform. Geography centers on Israel and the United States, with the firm maintaining offices in Herzliya and New York. Pitango HealthTech typically leads or co-leads rounds and holds board seats. Pitango HealthTech raised approximately $40M for its first fund in 2019 and $40M for its second fund in 2022, per Calcalist. The team includes around six investment professionals. The firm operates as a standalone venture firm but retains an affiliation with Pitango, which provides access to a broader network and co-investment opportunities. No recent operational events were publicly reported in the last 24 months. The firm's structural differentiator is its exclusive focus on digital health from inception, combining deep sector specialization with the infrastructure and network of a large multi-sector VC parent. This hybrid model — specialized thesis with institutional backing — is uncommon among healthtech funds of similar size. The firm also benefits from Pitango's long-standing relationships in Israeli and US tech ecosystems.
General information
Firm type
Venture Capital
Year founded
2019
AUM
Undisclosed
Location
Region
Middle East
Country
Israel
City
Herzliya
Corporate office
Herzliya, Israel
Additional offices
New York, United States
Principals
Itai Green
Managing Partner
Shai Levy
Managing Partner
Dr. Yossi Bornstein
Partner
Galit Biran
Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Pitango HealthTech?
Investment decisions are led by Managing Partners Itai Green and Shai Levy, who co-founded the firm. They are supported by Partners Dr. Yossi Bornstein and Galit Biran. The team draws on the broader Pitango network for deal sourcing and due diligence (per the firm's official communications).
How does Pitango HealthTech source proprietary deal flow?
The firm sources deals through its own network of healthcare executives, academic institutions such as Israeli hospitals and universities, and via the broader Pitango platform, which has invested in over 200 technology companies. Pitango HealthTech typically leads or co-leads rounds and takes board seats, which gives it visibility into emerging healthtech trends (per the firm's official communications).
Is Pitango HealthTech structured as a fund or a family office?
Pitango HealthTech is structured as a venture capital fund, not a family office. It operates as an independent affiliate of Pitango VC. The firm raises capital from institutional investors, including insurance companies and pension funds, and does not manage a single family's wealth (per public record).
What investment stages does Pitango HealthTech typically target?
The firm focuses on Seed and Series A rounds in digital health companies. It writes initial checks typically between $1M and $5M, and has capacity to co-invest larger amounts in follow-on rounds. The firm does not generally participate in later-stage or growth rounds (per the firm's official communications).
Which sectors does Pitango HealthTech explicitly focus on?
The firm focuses exclusively on digital health, including AI-powered diagnostics, virtual care, behavioral health technology, medical device cybersecurity, and healthcare data analytics. Portfolio companies include Cynerio (medical device security), Eleos Health (AI for mental health), and Ibex Medical Analytics (AI pathology). The firm does not invest in non-healthcare technology sectors (per public record).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: